Bristol-Myers Squibb Base awards $1.6 million in grants The Bristol-Myers Squibb Foundation announced $1.6 million in grants to four health care establishments in India that will help improve diabetes education, avoidance and care and boost healthcare worker capacity in rural and tribal areas and among the urban poor kjøpe propecia . The prevalence of diabetes in India has grown roughly four-fold because the early 1970s – from about 2 % of the populace in 1972 to 8.today – due to factors ranging from genetic predisposition to way of life and dietary changes 3 %. The International Diabetes Base reports that 61.26 million people in India are diagnosed with type 2 diabetes, ranking India second only to China in total cases and third behind america and China in terms of prevalence.
Five-12 months data from the Stage 3 study that evaluated the basic safety and efficacy of SPRYCEL in the treating Ph+ CML patients with resistance or intolerance to Gleevec may also be presented. Both models of results will be offered on Friday, 3 June. Bristol-Myers Squibb is normally developing ERBITUX together with Lilly. On Monday, 6 June, Phase 2 brivanib data in advanced soft tissue sarcoma may also be presented.. Bristol-Myers Squibb to provide abstracts on oncology substances in ASCO 2011 Annual Meeting Bristol-Myers Squibb Organization , a leading global BioPharma firm in oncology, today announced that a lot more than 95 scientific abstracts on its approved and investigational oncology compounds will be featured in the 47th Annual Conference of the American Society of Clinical Oncology in Chicago from June 3-7.